Inovio (INO) Stock: Here’s What You Need To Know

Inovio Pharmaceuticals (NASDAQ:INO) On Monday, Inovio Pharmaceuticals closed the day down by 17% after the company announced that the FDA had placed its trial initiation on hold. This refers to the phase 3 clinical trial that was supposed to begin shortly treating women with cervical dysplasia or CIN 2/3 lesions. The vaccine to be used … Read more